Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of serious infections in rheumatoid arthritis-a prospective Brazilian cohort.
de Almeida ALB, Guimarães MFBR, da Costa Pinto MR, Pereira LR, Reis APMG, Bonfiglioli KR, Louzada-Junior P, Giorgi RDN, de Castro GRW, Radominski SC, Brenol CV, Pugliesi A, da Mota LMH, da Rocha Castelar-Pinheiro G. de Almeida ALB, et al. Among authors: radominski sc. Adv Rheumatol. 2024 Mar 29;64(1):23. doi: 10.1186/s42358-024-00363-1. Adv Rheumatol. 2024. PMID: 38553751
Extra-articular manifestations of rheumatoid arthritis remain a major challenge: data from a large, multi-centric cohort.
Bonfiglioli KR, de Medeiros Ribeiro AC, Carnieletto AP, Pereira I, Domiciano DS, da Silva HC, Pugliesi A, Pereira LR, Guimarães MFR, Giorgi RDN, Reis APMG, Brenol CV, Louzada-Júnior P, da Cunha Sauma MFL, Radominski SC, da Mota LMH, da Rocha Castelar-Pinheiro G. Bonfiglioli KR, et al. Among authors: radominski sc. Adv Rheumatol. 2023 Jul 26;63(1):34. doi: 10.1186/s42358-023-00318-y. Adv Rheumatol. 2023. PMID: 37496102
Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study.
Albuquerque CP, Reis APMG, Vargas Santos AB, Bértolo MB, Júnior PL, Neubarth Giorgi RD, Radominski SC, Guimarães MFBR, Bonfiglioli KR, L Cunha Sauma MF, Pereira IA, Brenol CV, Henrique Mota LM, Santos-Neto L, Castelar Pinheiro GR. Albuquerque CP, et al. Among authors: radominski sc. Adv Rheumatol. 2023 Apr 24;63(1):17. doi: 10.1186/s42358-023-00301-7. Adv Rheumatol. 2023. PMID: 37095556
Decreasing delays in the diagnosis and treatment of rheumatoid arthritis in Brazil: a nationwide multicenter observational study.
de Albuquerque CP, Reis APMG, Santos ABV, Bértolo MB, Júnior PL, Giorgi RDN, Radominski SC, Resende Guimarães MFB, Bonfiglioli KR, da Cunha Sauma MFL, Pereira IA, Brenol CV, da Mota LMH, Santos-Neto L, Castelar Pinheiro GR. de Albuquerque CP, et al. Among authors: radominski sc. Adv Rheumatol. 2023 Feb 6;63(1):3. doi: 10.1186/s42358-022-00265-0. Adv Rheumatol. 2023. PMID: 36747307
Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program.
Kakehasi AM, Radominski SC, Baravalle MD, Palazuelos FCI, Garcia-Garcia C, Arruda MS, Curi M, Liu J, Qiao M, Velez-Sanchez P, Vargas JI. Kakehasi AM, et al. Among authors: radominski sc. Clin Rheumatol. 2023 May;42(5):1249-1258. doi: 10.1007/s10067-023-06513-y. Epub 2023 Jan 30. Clin Rheumatol. 2023. PMID: 36715850 Free PMC article. Clinical Trial.
Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study.
Santos IA, Donizeti Ribeiro de Oliveira R, Couto Luna Almeida S, Vargas-Santos AB, Balbino Chaves Amorim R, Monteiro Gomides AP, de Albuquerque CP, Barros Bertolo M, Brandão Resende Guimarães MF, da Costa Pinto MR, Gomes Resende G, Dalva Neubarth Giorgi R, de Carvalho Saciloto N, Radominski SC, Borghi FM, Rossi Bonfiglioli K, Carrico da Silva H, de Fatima L da Cunha Sauma M, Alves Pereira I, Werner de Castro GR, Viegas Brenol C, Machado Xavier R, Maria Henrique Mota L, Louzada-Junior P, da Rocha Castelar-Pinheiro G. Santos IA, et al. Among authors: radominski sc. PLoS One. 2022 Sep 29;17(9):e0273789. doi: 10.1371/journal.pone.0273789. eCollection 2022. PLoS One. 2022. PMID: 36174077 Free PMC article.
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis.
Smolen JS, Feist E, Fatenejad S, Grishin SA, Korneva EV, Nasonov EL, Samsonov MY, Fleischmann RM; CREDO2 Group. Smolen JS, et al. N Engl J Med. 2022 Aug 25;387(8):715-726. doi: 10.1056/NEJMoa2201302. N Engl J Med. 2022. PMID: 36001712 Clinical Trial.
Performance of the Rheumatoid Arthritis Disease Activity Index in the Assessment of Disease Activity in Rheumatoid Arthritis-Findings From the REAL Study.
Ramon Haddad PA, Vargas-Santos AB, Silva Freire Coutinho E, Rocha Pereira L, Henrique da Mota LM, Pires de Albuquerque C, Brandão de Resende Guimarães MF, Louzada-Júnior P, Rossi Bonfiglioli K, de Carvalho Sacilotto N, Radominski SC, Aliel Vigano Pugliesi A, Lobato da Cunha Sauma MF, Alves Pereira I, Viegas Brenol C, da Rocha Castelar-Pinheiro G. Ramon Haddad PA, et al. Among authors: radominski sc. J Clin Rheumatol. 2022 Jun 1;28(4):206-211. doi: 10.1097/RHU.0000000000001834. Epub 2022 Mar 22. J Clin Rheumatol. 2022. PMID: 35319537
Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study.
Vicente GNS, Pereira IA, de Castro GRW, da Mota LMH, Carnieletto AP, de Souza DGS, da Gama FO, Santos ABV, de Albuquerque CP, Bértolo MB, Júnior PL, Giorgi RDN, Radominski SC, Guimarães MFBR, Bonfiglioli KR, Sauma MFLDC, Brenol CV, da Rocha Castelar Pinheiro G. Vicente GNS, et al. Among authors: radominski sc. Adv Rheumatol. 2021 Jun 25;61(1):38. doi: 10.1186/s42358-021-00186-4. Adv Rheumatol. 2021. PMID: 34172097
76 results